Collectively, our results suggest that the inflammatory and gouty arthritis inhibitory effects of MPE primarily occur via the down-regulation of edema, pain and inflammation through the control of inflammasomes, proinflammatory cytokines (TNF-α and IL-1β), and NF-κB. This evidence concerns the gene NFKB1 and gout.